Principal Securities’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-276
Closed -$24.2K 2599
2025
Q3
$24.2K Buy
276
+34
+14% +$3.04K ﹤0.01% 2329
2025
Q2
$20.1K Buy
242
+4
+2% +$334 ﹤0.01% 2312
2025
Q1
$21.9K Hold
238
﹤0.01% 2145
2024
Q4
$21.9K Buy
238
+15
+7% +$1.44K ﹤0.01% 2141
2024
Q3
$20.7K Buy
223
+14
+7% +$1.21K ﹤0.01% 2103
2024
Q2
$17.2K Buy
209
+35
+20% +$2.57K ﹤0.01% 2137
2024
Q1
$11.5K Sell
174
-5
-3% -$309 ﹤0.01% 2258
2023
Q4
$10.2K Buy
+179
New +$9.38K ﹤0.01% 2232

Other funds holding LMAT

Principal Securities's LMAT Position: Q4 2025 in Review

Principal Securities sold out of LeMaitre Vascular (LMAT) in Q4 2025, closing a stake of 276 shares — an estimated $24.2K sold.

Principal Securities first reported a position in LMAT in Q4 2023 and held it in 8 quarters. The position peaked at $24.2K in Q3 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q4 2025.

  • Principal Securities reported no remaining LeMaitre Vascular position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 276 LeMaitre Vascular shares in Q4 2025, an estimated $24.2K.
  • Principal Securities first reported a position in LeMaitre Vascular in Q4 2023 and held it in 8 quarters.
  • Principal Securities's LeMaitre Vascular position peaked at $24.2K in Q3 2025.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.